Boston Bio Systems has informed that pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of our intimation dated 09th September, 2024 regarding Submission of Annual Report for the Financial Year 2023-24, the Company submitted the revised Annual Report for the FY 2023- 24.
The above information is a part of company’s filings submitted to BSE.